Answers are grounded in this paper and cite their sources.
Chronic kidney disease (CKD) alters vitamin D metabolism, but circulating 1,25-dihydroxyvitamin D [1,25(OH)₂D] is not a measure of vitamin D stores. This exploratory cross-sectional study examined its primary association with estimated glomerular filtration rate (eGFR) and secondary associations with urine albumin-to-creatinine ratio (ACR) and GFR categories in 53 complete records of patients with investigator-diagnosed CKD in Baghdad, Iraq. Analyses used Spearman’s rank correlation with bootstrap confidence intervals (CIs), Kruskal–Wallis tests, and regression of natural-log-transformed 1,25(OH)₂D with HC3 robust standard errors, adjusted for age, sex, and log₁₀ ACR. Mean age was 61.0 ± 17.1 years; 28 participants (52.8%) were male. Median eGFR was 41.0 mL/min/1.73 m² and median ACR was 533.0 mg/g. The reported 1,25(OH)₂D median was 2,279.5 fmol/L (interquartile range, 1,609.6–3,377.8), but assay identity, units, and calibration must be resolved before biological interpretation. Correlations were weak and nonsignificant for eGFR (ρ = 0.096; 95% CI, −0.165 to 0.341; P = .495) and ACR (ρ = 0.102; P = .466). Differences across G2–G4 categories were also nonsignificant (P = .442). The adjusted eGFR ratio was 1.115 per 10 mL/min/1.73 m² (95% CI, 0.984–1.264; P = .086). These exploratory estimates are inconclusive: nonsignificance does not establish absence of association. Assay and eligibility limitations preclude clinical classification or treatment recommendations. Validated assays and adequately powered prospective studies are needed.
No takes yet. Share an insight, caveat, or question.
Mutashar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: